Structural and lectin-detectable changes of liver induced by a long-term administration of antihistamine agent Loratadine


  • Olga Dudok Department of Histology, Cytology and Embryology, Danylo Halytsky Lviv National Medical University
  • Alexander Lutsyk Department of Histology, Cytology and Embryology, Danylo Halytsky Lviv National Medical University, Ukraine



rat liver histology, lectin histochemistry, H1-blocker Loratadine


Adverse effects of pharmacological agents are currently under considerable attention of theoretical and clinical medicine. The aim of present investigation was to study in experiment the effect of a long-term administration of antihistamine drug Loratadine on the micromorphology and carbohydrate determinants of the liver. Experimental rats once a day during 30 days intragastrically received Loratadine in the form of an aqueous suspension in the dose of 0.15 mg/kg body weight. On days 10, 30, 40, 50, 60 of experiment euthanasia was carried out, liver samples excised, fixed in 4% formaline and embedded in paraffin. Examination of haematoxylin and eosin stained sections revealed extension of sinusoid capillaries and central veins, granular dystrophy of hepatocytes supplemented with perivascular lymphoid infiltration, these phenomena receiving highest development on days 30th and 40th of experiment. At the same times PAS reaction demonstrated increased content of glycogen deposits in hepatocytes, apparently encompassing alterations in glucose metabolism. On the later stages of experiment (days 20th and 30th after the last Loratadine injection) signs of hepatocyte alteration decreased significantly, and content of glycogen returned to normal values. Loratadine administration induced the accumulation in the intra- and 2 perisinusoidal space of hepatic lobules of activated Kupffer cells, which were strongly PAS- and WGA-positive, as well as the enhanced exposure of DGlcNAc and DGalNAc determinants by glycoconjugates in within the altered hepatocytes. Our results indicate certain destructive effect of Loratadine on hepatic micromorphology and function; the cessation of this drug administration was accompanied by simultaneous strengthening of regenerative processes.


Download data is not yet available.


Navaro VS, Senior JR. Drug-related hepatotoxicity. N Eng J Med. 2006;354(7):731–739.

Holt MP. Mechanisms of drug-induced liver injury. American Association of Pharmaceutical Scientists Journal. 2006;8(1):48–54.

Bjorrnsson E, Olsson R. Suspected drug-induced liver fatalities reported to the WHO database. Dig Liver Dis. 2006;38:33–38.

William M, Lee MD. Drug-induced hepatotoxicity. N Eng J Med. 2003;349:474–485.

Malhi H, Gores GJ, Lemaster JJ. Apoptosis and necrosis in the liver. A tale of two deaths? Hepatology. 2006;43:31–44.

Borysova EO. Antihistamines: questions of security. Lechebnoe Delo. 2005;(2):37–43.

Drohovoz SM, Lukyanchuk VD, Sheyman BS, Kononenko AV. Toxic effect of histamine H1-receptor blockers and mechanisms of their formation. Modern Problems of Toxicology. 2012;3–4:44–48.

Kuzminov OB. Evaluation of immune toxic effects of loratadine on laboratory animals in the experiment. Experimental and Clinical Physiology and Biochemistry. 2014;1:43–46.

Sharon N. Lectins: carbohydrate-specific reagents and biological recognition molecules. J Biol Chem. 2007;282:2753–2764.

Gabius HJ (ed.). The sugar code: fundamentals of glycosciences. Weinheim: Wiley-Blackwell; 2009. p. 317–328.

Roth J. Lectins for histochemical demonstration of glycans. Histochem Cell Biol. 2011;136:117–130.

Dan X, Liu W, Ng TB. Development and applications of lectins as biological tools in biomedical research. Med Res Rev. 2015; DOI: 10.1002/med.21363.

Weakley BS. Electron microscopy for beginners. Moscow: Mir; 1975. p. 314.

Lutsyk A, Ambarova N, Antonyuk V. Diabetic alteration versus postnatal maturation of rat kidney glycoconjugates: comparative detection by lectin probes. Folia Histochem Cytobiol. 2013;51(1):92–102.

Antonyuk VO. Lectins and their resources. Lviv: Kvart; 2005. p. 554.

Dudok OV, Kovalyshyn VI, Lutsyk AD. Liver ultrastructure after administration of Loratadine. Acta Medica Leopoliensia. 2015;21(2):63–68.

Yvashkin VT, Nepomnyashchyh GN, Aydagulova SV. Drug-induced liver injury: Universal structural markers. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2009;12(2):20–29.

Kuznetsova LV. The role of liver in human immune system. Family Medicine. 2008;2:37–40.

Yakovleva LV, Lytvynenko GL, Loryanovska YB. Study of the most active derivatives among benzofuran derivatives (C 764–0334), 1.5 dyhidropirol-2-ones (VAZ-10) and 2,3-D-pyrimidine-6-carboxylic acid (L 486–0021) on liver function in healthy rats. Clinical Pharmacy, Pharmacotherapy and Medical Standardization. 2011;3–4:71–75.

Camelo-Nunes IC. New antihistamines: a critical view. J Pediatr (Rio J). 2006;82;5(Suppl.):173–180.

Berezhnaya NM, Kotova SA, Evseeva TA. Intracellular regulation of the functional state of lymphocyte H1- and H2- receptors in atopy – a possible criterion for individual selection of antihistamines. Allergology and Immunology. 2000;1(1):93–100.

Takeishi T, Mirano K, Kobayashi T et al. The role of Kupffer cells in liver regeneration. Arch Histol Cytol. 1999;62(5):413–422.

Deltsova OI, Gerashchenko SB, Kulinich GB. Stem cells and regeneration of liver. Scientific Bulletin of Uzhgorod University. 2012;1(43):175–179.

Yashchenko AM, Pankevych LV, Lutsyk AD. Rat liver carbohydrate alterations in streptozotocin-induced diabetic rats. Eur J Anat. 2012;16(2):82–90.




How to Cite

Dudok O, Lutsyk A. Structural and lectin-detectable changes of liver induced by a long-term administration of antihistamine agent Loratadine. JMS [Internet]. 2016 Jun. 30 [cited 2022 Jul. 2];85(2):114-20. Available from:



Original Papers